Investigating the molecular overlap and shared transcriptional signature between Polyendocrine Metabolic Ovarian Syndrome (PMOS) and ovarian cancer: an in-silico approach

Archives of Orthopaedic and Trauma Surgery · Springer Nature · 2026-11-04 · DOI: 10.1007/s43538-026-00985-7

Аннотация

Polyendocrine metabolic ovarian syndrome (PMOS) is the most common endocrine disorder in women of reproductive age. It affects around 8–13% of this population. It is associated with several other diseases, like cardiovascular disorders, type II diabetes, and obesity etc. Untreated prolonged PMOS can lead to uterine cancer and, to some extent, ovarian cancer (OC). Several studies have shown strong correlation between PMOS and uterine cancer. However, the association between PMOS and ovarian cancer, as well as the underlying molecular mechanisms leading to untreated PMOS to progress into OC, is still unclear. In this study, the authors performed a comparative bioinformatics analysis of publicly available RNA-seq datasets to identify overlapping differentially expressed genes and shared transcriptional signatures between PMOS and ovarian cancer. Several bioinformatics analyses, such as Differential Expression of Genes (DEG) analysis, functional and pathway enrichment analysis using the DAVID database, protein-protein interaction (PPI) network construction, and transcription factors (TFs) analysis of signature genes, were performed. The present study had identified 4045 and 4163 DEGs in PMOS and ovarian cancer patients, respectively, compared to normal controls. Among these, the study found 113 common DEGs in the PMOS and ovarian cancer datasets. In this study PPI network analysis was done to identify 113 common genes in the PMOS and OC datasets. Further, the study showed key genes associated with PMOS and ovarian cancer. A total of six candidate genes associated with the prognosis of OC were identified, and TFs of these signature genes were analysed. The study found that TFs of these genes, like MEIS1, SMAD4, ZNF3C, NFIX and ETV4 are regulated by androgen and insulin signalling pathways. The work proposes that PMOS-related metabolic disturbances (hyperinsulinemia, hyperandrogenism, and chronic low-grade inflammation) may change the transcriptional program in ovarian and associated tissues and potentially contribute to ovarian cancer in the long term.

Читать у издателя →

Похожие статьи